We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| DaVita Inc | NYSE:DVA | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 2.02 | 1.48% | 137.965 | 138.17 | 136.44 | 136.90 | 28,030 | 14:47:40 |
From Jul 2021 to Jul 2024
By Josh Beckerman
DaVita Inc. shares were down 15% at $75.84 after an unfavorable U.S. Supreme Court decision.
The stock opened at $90.36, up from Friday's close of $89.48, and was briefly paused due to volatility Tuesday morning.
The dialysis services company sued Marietta Memorial Hospital Employee Health Benefit Plan, arguing that the plan's limited coverage for outpatient dialysis violated the Medicare Secondary Payer statute.
The decision said, "we agree with petitioner Marietta" that it didn't violate the statute. The court reversed the judgment of the U.S. Court of Appeals for the Sixth Circuit and remanded the case for further proceedings.
DaVita Chief Executive Javier Rodriguez said in a statement that "alongside the kidney care community, we are deeply disappointed by today's Supreme Court decision to upend an important protection for Americans with chronic kidney failure." He added that "dialysis patients deserve better, and we'll continue to advocate for patient choice in care and coverage."
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
June 21, 2022 15:19 ET (19:19 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year DaVita Chart |
1 Month DaVita Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
